By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate leaders, working to create new methods for the treatment of mental health and other serious conditions.
Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M
May 10, 10:49 AM
Last week, the psychedelics space was moved by results from the world’s first Phase 3 clinical study of a scheduled psychedelic compound.
April 20, 2:54 PM
In recent years, there has been a re-emergence in the study of psychedelic drugs as a form of therapeutic treatment. After their height in popularity during the 1950s to early 1970s, psychedelics are now re-entering the medical field.